Article
Cardiosphere-Derived Cells Require Endoglin for Paracrine-Mediated Angiogenesis
1 May 2017
Abstract excerpt
Clinical trials of stem cell therapy to treat ischemic heart disease primarily use heterogeneous stem cell populations. Small benefits occur via paracrine mechanisms that include stimulating angiogenesis, and increased understanding of these mechanisms would help to improve patient outcomes. Cardiosphere-derived-cells (CDCs) are an example of these heterogeneous stem cell populations, cultured from cardiac...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
